Capital Network analyst Riccardo Lowi discusses Oxford Biomedica's (LON:OXB) market opportunity and says its research area is 'novel and promising'.
Capital Network's Lowi says Oxford Biomedica research area is 'novel and promising'
Quick facts: Oxford BioMedica plc
Price: 655 GBX
Market Cap: £503.43 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE